Table 2

Costs during RAPSID at baseline and study end*

	Baseline				Study end
	Control	1:1	Group	Combined	Control	1:1	Group	Combined
Out-of-pocket costs for participants	Mean Value				Mean Value
Medications	8.99	7.53	6.65	12.47	4.37	4.78	5.62	5.97
Glucose monitoring	2.21	3.12	6.47	3.81	6.27	9.12	13.64	11.22
Costs for medical visits†	74.57	86.13	151.15	112.71	49.69	51.65	86.40	64.40
Travel to appointments	16.95	15.25	23.06	17.69	36.10	39.70	43.49	48.65
Additional expenses‡	136.99	131.51	176.26	148.26	181.91	182.24	207.66	208.83
Total excluding covered services§,	156.15	149.87	205.79	169.76	224.29	231.06	264.79	268.71
Total including all costs¶	239.70	243.52	363.59	294.94	278.34	287.49	356.80	339.08
NHS incurred costs
Accident and emergency visits	274.63	321.32	329.84	303.17	389.66	365.66	408.04	471.12
Overnight hospital stay	329.73	516.66	341.82	962.86	796.63	948.68	902.03	991.14
Nurse and General Practitioner costs	166.60	160.86	166.82	156.99	100.18	93.78	101.77	100.45
Other health professionals	52.94	56.50	65.13	59.63	41.54	45.51	53.02	52.47
Total NHS incurred costs	823.90	1055.34	903.62	1482.66	1328.01	1453.63	1464.86	1615.19

*All costs reported in 2013 £.
ϮIncludes visits to general practitioner, practice nurse, dietician, and podiatrists.
‡Includes travel to appointments, expenses for weight loss group, additional healthcare-related costs for diabetes expenses, and costs for other health services.
§Excludes medication costs and payments for medical visits traditionally covered by the NHS.
¶Includes sum of all reported out of pocket costs.
NHS, National Health Service; RAPSID, RAndomized controlled trial of Peer Support in type 2 Diabetes.